[期刊]
  • 《Journal of Alzheimer's disease: JAD》 2022年85卷1期

摘要 : Background: Cognitive deficit is mainly clinical characteristic of Alzheimer's disease (AD). Recent reports showed adiponectin and its analogues could reverse cognitive impairments, lower amyloid-beta protein (A beta) deposition, ... 展开

相关作者
相关关键词